Skip to main content
Figure 7 | Journal of Translational Medicine

Figure 7

From: Effective visualization of integrated knowledge and data to enable informed decisions in drug development and translational medicine

Figure 7

Performance of ADAS-Cog test in different subpopulations of alzheimer’s disease visualized in the knowledge plot. The Plot demonstrates that there are different responsiveness in ADAS-Cog in different subpopulations of Alzheimer’s Disease, treated with Donepezil for 3 months. Data are coming from clinical trials reported in the literature [1216] where the Meaningful Effect is defined as a change of 2 scores from placebo in a three-month time-scale. The ADAS-Cog endpoint is the clinical outcome used in Alzheimer’s Disease trials.

Back to article page